Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1601 of 5804
-
New hope for Hard-to-Treat cancers: targeted drug tested in chinese patients
Disease control CompletedTo evaluate safety, tolerability, PK, and preliminary efficacy of AMG 510 PO QD in subjects of Chinese descent with KRAS p.G12C-mutant advanced/metastatic solid tumors.
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
13,000 volunteers shed light on who gets sick from COVID-19
Knowledge-focused Recruiting nowCOVIDENCE UK is a population-based observational longitudinal study that has the following objectives: 1. To determine risk factors for incident COVID-19 and for adverse outcomes of COVID-19 in the UK population 2. To characterise the natural history of COVID-19 in the UK popula…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Doctor-Tailored stent graft aims to tame deadly aortic aneurysms
Disease control Recruiting nowThe primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
ECMO studied in 761 severe COVID-19 patients: does it help?
Knowledge-focused CompletedThe role of ECMO in the treatment of patients with severe COVID-19 (Acute Respiratory Distress Syndrome (ARDS) and/or acute refractory heart failure) is not yet known. The present study will aim to report the results of the ECMO management of the most severe forms of COVID-19 thr…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
New vaccine combo targets rare liver cancer in early trial
Disease control Recruiting nowThe primary objective of the trial is the safety and tolerability of administering a vaccine targeting the DNAJB1-PRKACA fusion kinase, in combination with nivolumab and ipilimumab in patients with unresectable or metastatic FLC and with non-FLC solid tumors and to assess the T-c…
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Massive new study aims to stop Post-Surgery confusion in seniors
Prevention Recruiting nowThe project "QV-POD-2" is a prolongation based on "QV-POD-1", which was a quality contract program of the IQTIG - Institute for Quality and Transparency in Health Care. The aim is to improve inpatient care for older patients who are undergoing inpatient surgery and thus to specif…
Sponsor: Charite University, Berlin, Germany • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC
-
Can your own stem cells ward off COVID-19?
Prevention CompletedHope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) to provide immune support against COVID-19. The study purpose is to evaluate the safety and efficacy of five IV infusi…
Phase: PHASE2 • Sponsor: Hope Biosciences Research Foundation • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Promising drug combo targets Hard-to-Treat salivary cancer
Disease control CompletedThis study is an open-label phase 2 study to evaluate the safety and efficacy of Darolutamide monotherapy in patients with androgen receptor-positive salivary gland carcinoma. Moreover, this study will evaluate the safety and efficacy of Darolutamide and Goserelin combination in …
Phase: PHASE2 • Sponsor: National Cancer Center Hospital East • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New embryo test may boost IVF success without risky biopsies
Knowledge-focused CompletedThe objective of this study is to explore whether non-invasive chromosome screening (NICS) can be used as an effective indicator for embryos selection besides morphology through a multicenter randomized controlled trial, by comparing the differences of live birth rate, pregnancy …
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New combo aims to control lung cancer when immunotherapy fails
Disease control OngoingThis phase II trial studies how well MLN4924 (pevonedistat), carboplatin, and paclitaxel work in treating patients with stage IIIB or IV non-small cell lung cancer. Pevonedistat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemothera…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Plasma from COVID-19 survivors tested as treatment for the critically ill
Disease control CompletedThis is a prospective study, using plasma to help fight off infections of those suffering from COVID-19 in accordance with collection guidelines for plasma and FDA IND requirements. This study included up to 240 participants potentially receiving convalescent plasma. NOTE: West …
Phase: PHASE3 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can super-low breath volumes save COVID-19 patients on ventilators?
Disease control CompletedMortality of COVID-19 pneumonia with acute respiratory distress syndrome (ARDS) is extremely high in preliminary reports amounting to 50-60%. Duration of mechanical ventilation in these patients appears to exceed standard duration of mechanical ventilation in non-COVID-19 ARDS pa…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Supercharged immune cells take on tough B-Cell cancers in early trial
Disease control OngoingThis study is for patients who have lymphoma or leukemia that has come back or has not gone away after treatment. Because there is no standard treatment for this cancer, patients are being asked to volunteer for a gene transfer research study using special immune cells. The body…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug RC88 shows promise in early trial for hard-to-treat cancers
Disease control CompletedThis was a multicenter, open, multi-cohort extended PHASE I/IIa study, consisting of 2 phases:Phase I (Phase I dose escalation) and Phase II (Phase IIa multi-cohort extension). The objective of this study was to evaluate safety, tolerability, pharmacokinetic characteristics, and …
Phase: PHASE1, PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Pandemic puzzle: COVID-19's hidden impact on pregnancy revealed
Knowledge-focused Recruiting nowThe novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldwide pandemic. There is still much that is unknown regarding the virus, especially its effects on pregnancy, the fetus, and the neonate. This study seeks to evaluate adverse pregnancy and neonatal outcomes …
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New combo tackles resistant lung cancer in small trial
Disease control Completedusing Atezolizumab, a PD-L1 inhibitor, in combination with bevacizumab, platinum and pemetrexed to treat patients with EGFR mutated, advanced non-small cell lung cancer (NSCLC) after failure of EGFR tyrosine kinase inhibitors.
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study gives kids with relapsed cancer access to cutting-edge drugs outside clinical trials
Knowledge-focused Recruiting nowIt involves collecting safety and efficacy data, under the actual conditions of use of medicines in children and adolescents, using a validated tool (Ennov EDC) and relying on the network of Interregional pediatric oncology appeal organizations (RIOs) identified by INCa since 201…
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy aims to wipe out esophageal cancer before surgery
Disease control OngoingThis study evaluates a novel regimen of induction chemotherapy using a combination of docetaxel, oxaliplatin, and leucovorin, with short term infusional 5-FU (FLOT), given prior to chemoradiotherapy with concurrent carboplatin and paclitaxel, as neoadjuvant therapy prior to defin…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug combo shows promise for rare salivary gland cancer
Disease control OngoingThe purpose of the study is to evaluate the overall response rate (ORR) of apalutamide in combination with a gonadotropin-releasing hormone (GnRH) agonist in participants with androgen receptor (AR) expressing locally advanced or recurrent/metastatic salivary gland carcinoma (SGC…
Phase: PHASE2 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Gene therapy trial hopes to ease Parkinson's symptoms
Disease control OngoingThe objective of this Phase 1b investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects with either a recent or a long-standing diagnosis of PD.
Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated Jun 26, 2026 19:13 UTC